Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05337514 · ClinicalTrials.gov registry record · NA
Voice-Activated Technology to Improve Mobility in Multimorbid, Frail, Homebound Older Adults (EngAGE)
A NA study of Frailty, sponsored by University of Chicago.
- Active
- Registry status
- NA
- Development phase
- 137
- Enrollment target
- 1
- Study location
NCT05337514: Active NA study of Frailty, sponsored by University of Chicago.
NCT05337514 is a NA study of Frailty that is active but no longer recruiting, run by University of Chicago. The registered enrollment target is 137 participants, below the 1,503-participant average among 48 other Frailty trials with a reported enrollment target (91% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05337514, a NA study of Frailty, is active but no longer recruiting, sponsored by University of Chicago.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 137 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to test the efficacy of EngAGE (an interactive, voice-activated app) vs usual care on improving older adult physical and social function.
Primary Outcome
5 repeated chair stands
Conditions Studied
Interventions
- BEHAVIORAL Enhanced Engagement
- BEHAVIORAL Standard Engagement
Study Locations (1)
Illinois
- University of Chicago - Chicago
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 137 participants |
| Start Date | 2022-10-26 |
| Est. Completion | 2026-06-30 |
| Phase | NA |
What the registry record for NCT05337514 still lists
NCT05337514 is an interventional study that assigns participants to a tested intervention. The registered 137 participants enrollment target is mid-sized for trials with a published cap, below the 1,503-participant average among 48 other Frailty trials with a reported enrollment target (91% lower).
The record links to 1 condition, with Frailty appearing as the primary indexed condition, and to 2 interventions - of which Enhanced Engagement is the first listed.
NCT05337514 reports a single indexed study location in Illinois.
Frequently Asked Questions
What is clinical trial NCT05337514 about?
NCT05337514 is a clinical study titled "Voice-Activated Technology to Improve Mobility in Multimorbid, Frail, Homebound Older Adults (EngAGE)". The purpose of this study is to test the efficacy of EngAGE (an interactive, voice-activated app) vs usual care on improving older adult physical and social function.
What is the current status of trial NCT05337514?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 137 participants. The study started on 2022-10-26. Estimated completion is 2026-06-30.
What conditions does trial NCT05337514 study?
This clinical trial studies the following conditions: Frailty.
What interventions are being tested in trial NCT05337514?
The interventions under investigation include: Enhanced Engagement (BEHAVIORAL), Standard Engagement (BEHAVIORAL).
Who is sponsoring clinical trial NCT05337514?
This trial is sponsored by University of Chicago, which has 796 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05337514 being conducted?
This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Frailty
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05337514's enrollment target sits among peer trials
137 13th of 48 higher than 36 of 48 other Frailty trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Frailty trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
A Partnered Evaluation to Improve the Identification and Management of Functional Impairment and Frailty Among Older Veterans in Primary Care Settings
RECRUITING · NA
-
Occupational Therapy and Registered Dietitian Services to Reduce Fall Risk Among Home Delivered Meal Clients
RECRUITING · NA
-
Evaluate the Impact of Targeted Physical Activity on Clinically Debilitated Dialysis Patients.
RECRUITING · NA
-
Assisted Ambulation to Improve Health Outcomes for Older Medical Inpatients
RECRUITING · NA
-
Meal Delivery and Exercise
RECRUITING · NA
-
Nicotinamide Mononucleotide Supplementation for Exercise Tolerance Improvement in Healthy Older Adults
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05091424 · 137 participants · Phase 1
A Study Evaluating the Safety, Efficacy, and Pharmacokinetics of Mosunetuzumab and a Combined Regimen of Mosunetuzumab and Venetoclax in Participants With Relapsed or Refractory Chronic Lymphocytic Leukemia
- NCT05655182 · 137 participants · Phase 1
A Study of BLB-201 RSV Vaccine in Infants and Children
- NCT06571669 · 137 participants · NA
BOOM-IBD2 Pivotal Clinical Trial
- NCT06644768 · 137 participants · Phase 1
A Study of Valemetostat Tosylate Plus Pembrolizumab Versus Pembrolizumab Alone in First-Line NSCLC Without Actionable Genomic Alterations
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI